Skip to main content
Premium Trial:

Request an Annual Quote

Farfield Scientific, Aussie University to Co-Develop Protein-Analysis Tools

NEW YORK (GenomeWeb News) — Farfield Scientific will partner with Australia’s Monash University to develop biosensor surfaces to analyze protein functioning, UK-based Farfield said today.
The company said the aim of the collaboration, which has received funding from the Australian Research Council, is to commercialize membrane-mimetic biosensor surfaces to analyze the structure and functioning of membrane-associating peptides and proteins.
Monash project leader Mari-Isabel Aquilar said the collaboration with the school’s Department of Biochemistry and Molecular Biology will use Farfield’s AnaLight Bio2000 Dual Polarization Interferometry tool to analyze membrane surfaces, and develop and apply biosensor chips based on Monash’s IP for identifying new proteins and drug targets.
Farfield CEO Gerry Ronan said the research will create a bioanalytical toolkit that will “ultimately lead to an entirely new approach to structurally informed drug discovery.”

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.